Eagle Health Investments LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Eagle Health Investments LP disclosed 24 US equity positions worth $518.7m in its Q3 2024 13F filing. The largest position was NTRA at 10.6% of the reported book, followed by ILMN and ARGX.
What did Eagle Health Investments LP own in Q3 2024? Top 24 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | NTRA NATERA INC | Healthcare | 10.6% | $54.8m | 431,314 | – | |
| 2 | ILMN ILLUMINA INC | Healthcare | 9.7% | $50.5m | 387,354 | – | |
| 3 | ARGX ARGENX SE | Healthcare | 7.8% | $40.7m | 74,990 | – | |
| 4 | ICLR ICON PLC | Healthcare | 7.2% | $37.6m | 130,790 | – | |
| 5 | INSM INSMED INC | Healthcare | 7.2% | $37.5m | 513,700 | – | |
| 6 | EXK EXACT SCIENCES CORP | Basic Materials | 7.1% | $37.1m | 544,200 | – | |
| 7 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 6.0% | $31.2m | 561,700 | – | |
| 8 | DXCM DEXCOM INC | Healthcare | 5.8% | $30.3m | 451,492 | – | |
| 9 | UNH UNITEDHEALTH GROUP INC | Healthcare | 5.7% | $29.6m | 50,700 | – | |
| 10 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 5.7% | $29.5m | 419,212 | – | |
| 11 | INSP INSPIRE MED SYS INC | Healthcare | 5.6% | $28.8m | 136,603 | – | |
| 12 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 4.0% | $21.0m | 76,256 | – | |
| 13 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 3.7% | $19.4m | 54,099 | – | |
| 14 | PRCT PROCEPT BIOROBOTICS CORP | Healthcare | 3.6% | $18.7m | 233,089 | – | |
| 15 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.9% | $14.8m | 128,600 | – | |
| 16 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 2.8% | $14.7m | 330,830 | – | |
| 17 | FDMT 4D MOLECULAR THERAPEUTICS IN | 1.0% | $5.0m | 462,911 | – | ||
| 18 | LNTH LANTHEUS HLDGS INC | Healthcare | 0.9% | $4.7m | 43,200 | – | |
| 19 | ISRG INTUITIVE SURGICAL INC | Healthcare | 0.7% | $3.6m | 7,390 | – | |
| 20 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.5% | $2.8m | 45,000 | – | |
| 21 | TMDX TRANSMEDICS GROUP INC | Healthcare | 0.5% | $2.8m | 18,061 | – | |
| 22 | HOWL WEREWOLF THERAPEUTICS INC | 0.3% | $1.5m | 700,000 | – | ||
| 23 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 0.3% | $1.4m | 46,300 | – | |
| 24 | GRAL GRAIL INC | 0.1% | $731.0k | 53,124 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.